Leadership Team

The Leadership Team at OMEICOS Therapeutics is responsible for guiding the company's strategic direction, overseeing daily operations, and fostering innovation in the development of novel molecules for atrial fibrillation treatment. Comprising the Co-founder, CEO & CSO, CBO, and VP of Operations & IP, this team ensures alignment across departments and spearheads initiatives to achieve OMEICOS' mission and business goals.